ClinicalTrials.gov
ClinicalTrials.gov Menu

Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context of Option B+ for PMTCT? (E4E)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02070900
Recruitment Status : Unknown
Verified February 2014 by WHO, Department of Maternal, Newborn, Child and Adolescent Health.
Recruitment status was:  Recruiting
First Posted : February 25, 2014
Last Update Posted : February 25, 2014
Sponsor:
Collaborators:
Canadian International Development Agency
Netherlands: Ministry of Health, Welfare and Sports
Information provided by (Responsible Party):
WHO, Department of Maternal, Newborn, Child and Adolescent Health

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2015
  Estimated Study Completion Date : July 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):